So on top of the $125k which PTOI 8-k'd in July 2018 as

New Post Public Reply Private Reply Replies (0) Message Board
PaperProphet
414
So on top of the $125k which PTOI 8-k'd in July 2018 as debt financing from director Mr. Brain, on Aug 7, 2018 CEO Mr. Heddle put out a press release, "The Company secured additional debt financing commitments from two current directors for approximately $250,000 for the intended use of initially restarting one of its processors in such a way that should allow the Company to process used oils and film plastics."

Presumably "additional" really means additional since the $125k from Mr. Brain was already announced...meaning $375k supposedly went onto the balance sheet during the third quarter. However by the end of the third quarter, cash only went up $70k and PTOI still was "unable to obtain the financing necessary to make these repairs."

Investors should be up in arms about PTOI's steady stream of tricks and ruses...yet nothing. Investors don't seem to want to say anything which might lead others to sell because they don't want the $0.02 stock price to be hurt. Many even despise anyone who says anything bad about PTOI.

I'm sure many investors want to give Mr. Heddle the benefit of the doubt once again and assume he really did spend that money to try to fix the processors but merely failed. For a person who wants to believe, there's always the benefit of the doubt to give when a company barely says anything that isn't vague or ambiguous.

If shareholders staying silent isn't enough, the dishonest moderator here adds another layer of filtration by targeting for deletion the posts of those people who don't share her opinion. Deleting for even the tiniest of infractions and making up rules of her own to expand the net. Not too long ago in one paragraph of a post I said that PTOI shareholders lost money since the share price was down and the moderator said that was "factually false" because she believes nobody loses money until they actually sell their stock. She deleted the entire post with that excuse. My sentence wasn't confusing nor disruptive--she's just continuing her work to silence PTOI's critics as much as she can.

From the company blatantly and routinely screwing over shareholders all the way to the shareholders themselves who keep a stiff upper lip because they want the stock pumped, PTOI is a self-sustaining scam. Is it any wonder why there are so many scams when the victims themselves feel aligned to help the swindlers rip off more victims??

I asked this before, but what exactly would have to happen before the remaining shareholders start to suspect that PTOI isn't all it pretends to be?? How much fraud, deception and excuses need to be present before PTOI's investors start to see some red flags?



Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Scienjoy's Strategic Stake in Education: Bold Move?

Updated Category News Views 1

Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....

Continue Reading
Veteran Suicide Prevention: The Urgency Behind CVN's Push

Updated Category News Views 3

Veteran suicide is a crisis staring us square in the face, with rates 60% higher than the general population. It's a grim reminder that the mental toll on those who've served is a deep chasm hard to bridge. Cohen Veterans Network (CVN) is stepping up to the plate with a new campaign dubbed 'Ask Anyway: Conversations to Save a Life'. This isn't just any awareness...

Continue Reading
Battling Razor Bumps: Breaking a Persistent Cycle

Updated Category News Views 4

Understanding Razor Bumps: More Than a Cosmetic Annoyance Crossing Great Neck this morning, I stumbled across a curious release from Laser by Aleya. Apparently, the problem with those pesky razor bumps plaguing many isn't just skin-deep. For some, especially those with coarse or curly hair, each razor stroke starts a relentless cycle of irritation that's as grinding as...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 3

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 4

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Qapture Expands Global DeFi Reach with Key Acquisitions

Updated Category News Views 2

Qapture Investments just made a move in the digital finance space that's promising to turn some heads. From acquiring Flammarion Partners to snapping up Hermetik Trading's DeFi strategies, this Bermuda-based investment manager isn't here to play. Led by Frederick Pye, the firm's gearing up for an industry takeover by blending regulation with innovative digital finance...

Continue Reading
Intrigue Over Guadalupe River Property Bid

Updated Category News Views 2

Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 2

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Three Lions Acquisition Corp: $100M IPO Hits Nasdaq

Updated Category News Views 3

Three Lions Joins the SPAC Playground The market's buzzing today as Three Lions Acquisition Corp. sauntered in with a $100M debut. Yep, they're the latest Special Purpose Acquisition Company out to net some big fish in the sports, hospitality, and real estate waters. A blank check company raising this kind of dough ain't exactly a novelty, but it never fails to turn a few...

Continue Reading
Epson & The Photo Managers Highlight Memories in Sept.

Updated Category News Views 8

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading